Back
Synopsys, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
40
SNPS
Synopsys, Inc.
Last Price:
$465.83
Seasonality Move:
-0.51%
Buy
90
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
Sell
40
Synopsys, Inc. (SNPS)
is a Sell
Is Synopsys, Inc. a Buy, Sell or Hold?
-
The current Synopsys, Inc. [SNPS] share price is $465.75. The Score for SNPS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SNPS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SNPS Stock Price Chart
What is Synopsys, Inc.'s stock price today?
-
The Synopsys, Inc. share price today is $465.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPS is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $94.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
SNPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.11 | Buy |
| Relative Strength Index (14 RSI): | 67.16 | Buy |
| Chaikin Money Flow: | 636641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (386.04 - 442.62) | Buy |
| Bollinger Bands (100): | (417.99 - 591.51) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 86.88 | Buy |
| Chaikin Money Flow: | -462379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.8 - 71.72) | Buy |
| Bollinger Bands (100): | (43.38 - 63.26) | Buy |
SNPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 447.25 | Buy |
| 20-day SMA: | 414.88 | Buy |
| 50-day SMA: | 438.16 | Buy |
| 200-day SMA: | 488.19 | Sell |
| 8-day EMA: | 448.79 | Buy |
| 20-day EMA: | 431.83 | Buy |
| 50-day EMA: | 444.64 | Buy |
| 200-day EMA: | 488.74 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 66.61 | Buy |
| 50-day SMA: | 61.97 | Buy |
| 200-day SMA: | 44.25 | Buy |
| 8-day EMA: | 72.36 | Buy |
| 20-day EMA: | 67.57 | Buy |
| 50-day EMA: | 61.93 | Buy |
| 200-day EMA: | 49.42 | Buy |
Synopsys, Inc. Earnings Growth & SNPS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $1.21 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
Synopsys, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||